Cancer news and cancer widget

EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, announced that it has met the primary endpoint for the efficacy portion of the open label Phase 1/2 study of MKC-1 in combination with pemetrexed (Alimta(R)) in non-small cell lung cancer patients.

There is no reason why the best drugs cannot be available to all NHS patients, the Keep Our NHS Public campaign has said, but the government has wrongly excluded this option from the current consultation over cancer drugs.

Spectrum Pharmaceuticals, Inc., (NasdaqGM:SPPI) announced today that the Centers for Medicare and Medicaid Services (CMS), under the Medicare Part B benefit, has assigned a unique, product-specific billing code, or J-code, for FUSILEVT (levoleucovorin). FUSILEVT is the only commercially available formulation comprised only of the pharmacologically active isomer of leucovorin.

Nurses in dermatology settings are conducting high-quality screenings to identify suspicious lesions and non-melanoma skin cancer. In the October 2008 issue of Dermatology Nursing, Deborah L. Phelan and Maureen Heneghan explore how dermatology nurses participate in skin cancer screening and detection in their practices.

Cancer cells are already stressed by the fast pace they require to grow and spread and scientists believe a little more stress just may kill them. "Think about an assembly line in a factory that is working five times faster than normal," said Dr. Kapil Bhalla, director of the Medical College of Georgia cancer Center. "There is a lot of stress but you need workers to keep going. Some of them fall out, some get bent out of shape.

Ewing sarcoma is the second most common type of primary bone cancer seen in children and young adults. patients with relapsed or refractory Ewing sarcoma have a poor outcome with conventional therapies. Cytarabine decreases the levels of a certain key protein in Ewing sarcoma cells and has demonstrated preclinical activity against Ewing sarcoma cell lines in the laboratory. Treatment of Ewing sarcoma that relapses is difficult.

(University of Nottingham) A new technique to study genetic changes that can lead to breast cancer could be one step closer.

A study of 84,285 women seeking care in Dutch family physician offices between 1985 and 2003 revealed that breast symptoms were reported in about 3 percent of all visits. Of the women complaining of breast symptoms, 3 percent of those women were subsequently diagnosed with breast cancer. Notably, those patients reporting a breast mass had a markedly elevated likelihood of breast cancer (15.

(Louisiana State University health Sciences Center) Professor Vivien Chen, Ph.D., Associate Professor Xiao Cheng Wu, M.D., Ph.D. and Assistant Professor Edward Peters, D.M.D., S.M., Sc.D., at LSU Health Sciences Center New Orleans School of Public Health contributed five papers to the largest most comprehensive assessment of the burden of human papillomavirus-associated cancers in the United States to date.

(American Association for cancer Research) The American Association for Cancer Research?s Seventh Annual International Conference on Frontiers in Cancer Prevention Research will focus on the latest biological, medical and social research behind cancer prevention. The conference will be held Nov. 16 - 19, 2008, at the Gaylord National Convention Center in Washington, D.C. and more than 1,000 scientists and other professionals are expected to attend.